3-Hydroxybutyric acid

From NuGOwiki

(Redirected from HMDB00357)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

3-Hydroxybutyric acid
2D structure for 3-Hydroxybutyric acid
Chemical Name 3-hydroxybutanoic acid
Chemical Formula C4H8O3
CAS Number 300-85-6
Chemical Information HMDB00357
Biochemical Taxonomy

  • Hydroxy Acids

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Cellular Cytoplasm
  • Cerebrospinal Fluid (CSF)
  • Urine

Tissue Location

  • Liver
  • Neurons
  • Brain

Normal Biofluid Concentrations

  • Blood: 100.0 +/- 90.0 uM
  • Blood: 180.0 (22.0-700.0) uM
  • Blood: 323.0 +/- 29.0 uM
  • Blood: 36.0 (13.0-95.0) uM
  • Blood: 40.0 +/- 10.0 uM
  • Blood: 50.0 (0.0-100.0) uM
  • Blood: 565.0 +/- 255.0 uM
  • Blood: 60.0 +/- 20.0 uM
  • Cellular Cytoplasm: 1300 (1200-1400) uM
  • Cerebrospinal Fluid (CSF): 34 +/- 31 uM
  • Cerebrospinal Fluid (CSF): 46.4 +/- 23.9 uM
  • Cerebrospinal Fluid (CSF): 48.0 +/- 48.0 uM
  • Cerebrospinal Fluid (CSF): 50.0 (4.0 - 96.0) uM
  • Urine: 1.3 (0.1-5.8) umol/mmol creatinine
  • Urine: 1.4 (0.1-2.7) umol/mmol creatinine
  • Urine: 2.0 (0.5-9.8) umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Anoxia
  • Obesity
  • Patients with acute ethanol intoxication
  • Type 1 diabetes

Other (Monogenic Disorders)

Abnormal Biofluid Concentrations

  • Blood (Obesity): 235.0 +/- 17.0 uM
  • Blood (Patients with acute ethanol intoxication): 21770.0 +/- 9111.0 uM
  • Blood (Type 1 diabetes): 35.5 +/- 92.2 uM
  • Cellular Cytoplasm (Anoxia): 2600 (2500-2700) uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
It is one of the ketone bodies produced in the liver and occurs at high levels in the blood and urine in ketosis. Persistent mild hyperketonemia is a common finding in newborns. These compounds serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first 2 weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life. (PMID 3884391)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Anoxia
  • Obesity
  • Patients with acute ethanol intoxication
  • Type 1 diabetes

Other (Monogenic) Disorders

guidelines

Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines